BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12120411)

  • 1. Cytochrome P450 enzymes in the generation of commercial products.
    Guengerich FP
    Nat Rev Drug Discov; 2002 May; 1(5):359-66. PubMed ID: 12120411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 monooxygenases: perspectives for synthetic application.
    Urlacher VB; Eiben S
    Trends Biotechnol; 2006 Jul; 24(7):324-30. PubMed ID: 16759725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 networks in chemical space.
    Lee S; Kim D
    Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
    Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
    Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates.
    Cohen LH; Remley MJ; Raunig D; Vaz AD
    Drug Metab Dispos; 2003 Aug; 31(8):1005-15. PubMed ID: 12867489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
    Gillam EM
    Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochromes P450 as useful biocatalysts: addressing the limitations.
    O'Reilly E; Köhler V; Flitsch SL; Turner NJ
    Chem Commun (Camb); 2011 Mar; 47(9):2490-501. PubMed ID: 21264369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.
    Lanza DL; Yost GS
    Drug Metab Dispos; 2001 Jul; 29(7):950-3. PubMed ID: 11408359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 proteins and potential utilization in biodegradation.
    Guengerich FP
    Environ Health Perspect; 1995 Jun; 103 Suppl 5(Suppl 5):25-8. PubMed ID: 8565903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
    Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
    IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome mining approach for the discovery of novel cytochrome P450 biocatalysts.
    Furuya T; Kino K
    Appl Microbiol Biotechnol; 2010 Apr; 86(4):991-1002. PubMed ID: 20177889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.